In Romanian cohorts with PreDM and newly diagnosed T2DM, we previously demonstrated that pentraxin 3 along with other inflammatory biomarkers are already elevated and show correlations with various obesity indices, reinforcing the idea that low-grade inflammation is associated with early dysglycemia [11]. This evidence concerns the gene PTX3 and obesity disorder.